Amarogentin

For research use only. Not for therapeutic Use.

  • CAT Number: I018524
  • CAS Number: 21018-84-8
  • Molecular Formula: C₂₉H₃₀O₁₃
  • Molecular Weight: 586.54
  • Purity: ≥95%
Inquiry Now

Amarogentin(Cat No.:I018524)is a bioactive compound derived from the plant Gentiana lutea, known for its bitter properties and potential health benefits. It is a secoiridoid glycoside that exhibits anti-inflammatory, antioxidant, and antimicrobial activities. Research suggests that amarogentin may play a role in digestive health by stimulating gastric secretions and promoting appetite. Additionally, it has been studied for its potential neuroprotective effects and ability to modulate various signaling pathways. Amarogentin’s diverse pharmacological properties make it a valuable subject of investigation in herbal medicine and therapeutic applications.


Catalog Number I018524
CAS Number 21018-84-8
Molecular Formula C₂₉H₃₀O₁₃
Purity ≥95%
Target PI3K/Akt/mTOR
Storage 2-8°C
IUPAC Name [(2S,3R,4S,5S,6R)-2-[[(3S,4R,4aS)-4-ethenyl-8-oxo-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate
InChI InChI=1S/C29H30O13/c1-2-16-17-6-7-38-26(36)19(17)12-39-28(16)42-29-25(24(35)23(34)21(11-30)40-29)41-27(37)22-18(9-15(32)10-20(22)33)13-4-3-5-14(31)8-13/h2-5,8-10,12,16-17,21,23-25,28-35H,1,6-7,11H2/t16-,17+,21-,23-,24+,25-,28+,29+/m1/s1
InChIKey DBOVHQOUSDWAPQ-WTONXPSSSA-N
SMILES C=C[C@@H]1[C@@H]2CCOC(=O)C2=CO[C@H]1O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)OC(=O)C4=C(C=C(C=C4O)O)C5=CC(=CC=C5)O
Reference

[1]. Zhang Y, et al. Protective Effects of Amarogentin against Carbon Tetrachloride-Induced Liver Fibrosis in Mice. Molecules. 2017 May 6;22(5). pii: E754.<br>[2]. Wölfle U, et al. Amarogentin Displays Immunomodulatory Effects in Human Mast Cells and Keratinocytes. Mediators Inflamm. 2015;2015:630128.<br>[3]. Zhao JG, et al. Amarogentin secoiridoid inhibits in vivo cancer cell growth in xenograft mice model and induces apoptosis in human gastric cancer cells (SNU-16) through G2/M cell cycle arrest and PI3K/Akt signalling pathway. J BUON. 2016 May-Jun;21(3):609-17.

Request a Quote